NCT00691522View on ClinicalTrials.gov

Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)

PHASE2TerminatedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

October 31, 2009

Conditions
Peritumoral Brain EdemaPRIMARY MALIGNANT and METASTATIC BRAIN TUMORS
Interventions
DRUG

Xerecept

Sponsors

Lead Sponsor

PharmaNet
All Listed Sponsors
collaborator

Celtic Pharma Development Services

INDUSTRY

lead

PharmaNet

INDUSTRY

NCT00691522 - Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE) | Biotech Hunter | Biotech Hunter